Breast-Cancer Risk in Families with Mutations in PALB2 — NEJM

Breast-Cancer Risk in Families with Mutations in PALB2 — NEJM

Hereditary Breast & Ovarian Cancer: New Genetic Insights & Implementation

New findings: Breast-cancer risk in families with mutations in PALB2

Antoniou AC, et al. New England Journal of Medicine2014 Aug 13

PALB2 mutations and breast-cancer risk 

Evans MK & Longo DL N Engl J Med 2014 Aug;371(6):566-8

Study shows third gene as indicator for breast cancer, by Nicholas Bakalar, The New York Times, Aug 6

Another gene identified as increasing breast cancer risk, Associated Press, Aug 6

Breast-cancer predisposition in multiple endocrine neoplasia type 1

N Engl J Med 2014; 371:583-584 August 7, 2014

It's rare, but yet another breast cancer gene identified, Medscape, Aug 11 [by free subscription only]

CDC sponsored study findings: Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: A statewide initiative.

Brannon Traxler L, et al. Ann Surg Oncol. 2014 Jul 22

Public Health Genomics Implementation Tool Kit for health departments- check out BRCA section

CDC initiative Know:BRCA. In the US, 9,000 women younger than 40 years are diagnosed every year with breast cancer.  In this younger group, breast cancer is generally more aggressive, found at a later stage, and has lower survival rates

CDC BRCA assessment tool for women: The Know:BRCA Assessment can help you assess your risk of having a BRCA mutation. Learning your risk can help you and your doctor make important decisions for your health

CDC BRCA assessment tool for clinicians: Help women Know: BRCA